Identifying compounds that interact with key AD-related targets, such as AChE, APP, BACE1, MAPT, PSEN1, TNF-α, and VCP, highlights their probable influence on critical pathways central to AD pathogenesis. This evidence concerns the gene ACHE and Alzheimer disease.